As CEO of Base Pair Biotechnologies, Bill has been leading the development and commercialization of aptamer-based diagnostics and therapeutics for over 12 years. In addition to private capital, Dr. Jackson has also secured significant non-dilutive funding through government grants and contracts as well as revenue from early-stage products and services. He has served as principal investigator on more than 20 federally funded research projects and established collaborations with clinicians and researchers at world-class research institutions and universities. Bill also serves frequently as a panel reviewer regarding molecular diagnostics and related tools, environmental monitoring, and biodefense. His stated mission is to leverage the potential of aptamers to create innovative solutions for global health and environmental challenges, and to advance the field of aptamer science and technology.My specialties and keywords include: molecular diagnostic development, bioinformatics, chemical biology, nanotechnology, microfluidic device and assay development, siRNA, aptamer development, gene delivery, biosensing, mass spectrometry, bacteriology, grant writing, SBIR program expertise, review panels, project management, data analysis and synthesis, inventing and patent prosecution.For a current list of all publications, see:https://www.researchgate.net/profile/Bill-Jackson-3